SIRT1 overexpression has already been found in several tumor cells, including acute myeloid leukemia (AML) and primary colon, prostate, melanoma, and non-melanoma skin cancers, whereas SIRT1 low-expression was demonstrated in breast cancer and hepatic cell carcinomas [13]. The gene discussed is SIRT1; the disease is breast cancer.